Guided Therapeutics OTC Stock Executives
| GTHP Stock | USD 0.19 0.03 18.75% |
Guided Therapeutics employs about 5 people. The company is managed by 2 executives with a total tenure of roughly 18 years, averaging almost 9.0 years of service per executive, having 2.5 employees per reported executive. Discussion of Guided Therapeutics' management performance can provide insight into the enterprise performance.
| Gene Cartwright CEO CEO and President Acting CFO and Director |
Guided |
Guided Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.6278) % which means that it has lost $0.6278 on every $100 spent on assets. This is way below average. Guided Therapeutics' management efficiency ratios could be used to measure how well Guided Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Guided Therapeutics Workforce Comparison
Guided Therapeutics is one of the top stocks in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 142. Guided Therapeutics holds roughly 5.0 in number of employees claiming about 4% of all equities under Medical Devices industry.
Guided Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Guided Therapeutics Price Series Summation is a cross summation of Guided Therapeutics price series and its benchmark/peer.
Guided Therapeutics Notable Stakeholders
A Guided Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Guided Therapeutics often face trade-offs trying to please all of them. Guided Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Guided Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gene Cartwright | CEO and President Acting CFO and Director | Profile | |
| Mark Faupel | Chief Scientific Officer | Profile |
About Guided Therapeutics Management Performance
The success or failure of an entity such as Guided Therapeutics often depends on how effective the management is. Guided Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guided management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guided management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. Guided Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 5 people.
The data published in Guided Therapeutics' official financial statements typically reflect Guided Therapeutics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Guided Therapeutics' quantitative information. For example, before you start analyzing numbers published by Guided accountants, it's essential to understand Guided Therapeutics' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Guided Therapeutics Workforce Analysis
Traditionally, organizations such as Guided Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Guided Therapeutics within its industry.Guided Therapeutics Manpower Efficiency
Return on Guided Therapeutics Manpower
| Revenue Per Employee | 16.2K | |
| Revenue Per Executive | 40.5K | |
| Net Loss Per Employee | 414K | |
| Net Loss Per Executive | 1M |
Additional Tools for Guided OTC Stock Analysis
When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.